Abstract The World Health Organization-Composite
Introduction: standardized diagnostic interviews for the assessment of mental disorders Several diagnostic instruments exist for the assessment of mental disorders in clinical and epidemiological research. These include the Structured Clinical Interview for DSM-III-R (SCID) , the MINI International Neuropsychiatric Interview (M.I.N.I.) (Sheehan et al. 1998) ; the Schedule for Affective Disorders and Schizophrenia (SADS) (Endicott and Spitzer 1978) , the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (van Gülick-Bailer et al. 1995) , the Diagnostic Interview Schedule (DIS) (Robins et al. 1981) , the Present State Examination (PSE) (Wing et al. 1974 ) and the Composite International Diagnostic Interview (CIDI) (Wittchen et al. 2001) . The most frequently used tool in clinical and community epidemiological studies worldwide is the World Health Organization-Composite International Diagnostic Interview (WHO-CIDI) (Robins et al. 1988; Wittchen et al. 1991; Wittchen 1994; Kessler and Üstün 2004) . Based on its predecessor, the DIS, for DSM-III and DSM-III-R (APA 1980 (APA , 1987 , the CIDI was the product of a close collaboration with the authors of the PSE, within the context of WHO/ADAMHA Task Force on Diagnostic Classification and Instruments (Lépine et al. 1993; Semler et al. 1987; Wittchen and Nelson 1996) . An attempt was made at the time, to cover within one instrument the definitions, criteria and diagnostic algorithms of both the ICD-10 (WHO 1993, Diagnostic Criteria for Research) and the DSM-IV (APA 2000) . Since then several versions, modifications and variants of the CIDI have been developed for use in small and large scale epidemiological and clinical studies for lifetime, 12-month and cross-sectional diagnoses; additionally interval and change-versions for longitudinal research became available, supplemented by various additional diagnostic modules (Andrews and Wittchen 1995; Cottler et al. 1991; Kessler and Üstün 2004; Kessler et al. 1998a Kessler et al. , b, 2000 Lachner and Wittchen 1996; Lieb et al. 2000; Rubio-Stipec et al. 1993; Wittchen et al. 1995 Wittchen et al. , 1998 Wittchen and Pfister 2004 ; overview see Wittchen et al. 2001) . It is important to note that the diagnostic algorithms were retained in all versions, thus allowing for cross-walks from earlier to later versions even when changes in the diagnostic system occurred. Divided into 16 diagnostic sections, the CIDI allows the fully standardized symptom and syndrome assessment of a total of 56 core diagnoses of mental disorders including information regarding onset, recency, severity, and impairment as well as patterns of co-morbidity. It offers also some crude information about help seeking and health care utilization, and provides data about the temporal relationships of syndromes by incorporation of symptom and timerelated questions for persistence and duration. Symptom questions address problems that the respondent has experienced, probing additionally for significance and causation (i.e. substance induced/ or due to general medical conditions) as well as for symptoms that have occurred in the person's lifetime or in other time-frames (e.g., past 12 months). Diagnoses of mental disorders can be obtained for the corresponding time-frames (current: 2 or 4 weeks, 12 months, lifetime) by the use of computerized algorithms . The CIDI is a standardized diagnostic interview. The interviewer is instructed to ask all questions exactly as written, to code the respective answer of the respondent (interviewers are not allowed in the interview to code clinical impression, except for supplementary observational items), and to follow the fixed skip rules to enhance efficiency. All interview questions must be read exactly as written and the interviewer should not rephrase the question (Kessler and Üstün 2004; Wittchen and Semler 1990 ). The administration is further facilitated by the use of a Respondent Booklet, providing a visual presentation of more complex response options, symptom lists, and dimensional questionnaires. The CIDI can be administered by non-clinicians given appropriate standard training. Learning the CIDI requires a training seminar of several days up to one week duration for the paper and pencil administration and 2 to 3 days for the Computer Assisted Personal Interview (CAPI) version. The CIDI is applicable for the age groups of 14 to 65 years and for respondents from different cultural and educational background (Robins et al. 1988) . Respondents with severe intellectual disturbances, dementia or acute psychotic states should be excluded on the basis of the optional CIDI MiniMental Examination module (Wittchen and Pfister 1997) .
In summary, the CIDI is easy to administer, available in several languages and has established reliability and validity (Andrews and Peters 1998; Essau and Wittchen 1993; Kessler et al. 1998a, b; Knappe et al. 2008; Lachner et al. 1988; Reed et al. 1998; Spengler and Wittchen 1988; Wittchen et al. 1989 Wittchen et al. , 1998 Wittchen et al. , 1999 .
The need for a female-specific diagnostic interview
Over the past decade it became increasingly evident, that neither the CIDI nor other standard diagnostic interviews provide sufficiently detailed information about femalespecific disorders, such as PMDD, female-specific characteristics of psychopathological presentations such as mental disorders with post-partum onset, the relationship of characteristics of the menstrual cycle with psychopathology and peri-and post menopausal manifestations of syndromes (Soares and Zitek 2008; Steiner et al. 2003a; Yonkers and McCunn 2007) . Given the increased psychopathological burden for women associated with most diagnoses (Andrade et al. 2003) , the lack of such an instrument has also impeded the accumulation of better clinical-epidemiological information regarding the core factors associated with the increased incidence and prevalence of mental disorders in women. Epidemiological studies consistently show that with the onset of the reproductive years at menarche, mood disorders are at least twice as common in women than in men (Kessler 2003; Lewinsohn et al. 1998; Steiner et al. 2003a; Wittchen and Jacobi 2005) . A similar gender-specific pattern is also evident in anxiety, eating and somatoform disorders as well as with regard to the type and extent of comorbid patterns (Escobar et al. 1989; Fairburn and Harrison 2003; Rief et al. 2001; Wittchen and Jacobi 2005; Yonkers and McCunn 2007) . There is also considerable evidence that onset, course, and prognosis of these disorders may be different for men and women (Fehm et al. 2005; Wittchen and Jacobi 2005) .
Due to the fact that almost all epidemiological instruments do not address the specific characteristics of women's reproductive years, it has been difficult to relate psychopathological syndromes and their course to core female-specific issues, such as the menstrual cycle, pregnancy, postpartum, and menopause (Steiner et al. 2003a; Yonkers and McCunn 2007) . Additionally, some disorders that are exclusively relevant to women such as PMDD and Perinatal and Perimenopausal Disorders are not covered by the existent standard diagnostic tools. Despite the wide range of instruments available that specifically address some of these critical issues, these tools are typically questionnaires covering only a few domains and can not easily be embedded into one coherent and conceptually sound assessment instrument. Thus, except for some recent attempts to supplement the standard CIDI with femalespecific diagnostic categories such as PMDD (Wittchen et al. 2002) , so far-and to our knowledge-there is no instrument covering a broader spectrum of women-specific mental disorders.
Designing a female-specific diagnostic interview
In response to this marked deficit, the authors convened a working group to explore existing instruments and their suitability for developing a female-specific diagnostic assessment tool. The group decided, after careful review of existing evidence, on the following principles:
1. The instrument should be a modification of an existing instrument, rather than a new stand-alone instrument. This should allow for easy comparison of any newly generated female specific data with existing data bases. 2. In-depth psychometric analyses should be performed on all newly-added as well as modified modules and sections.
3. The standardized interview approach should be maintained to increase inter-rater reliability and to ensure consistency between different research groups and different settings. 4. A lifetime interview approach in addition to crosssectional data should be used to ensure lifetime information about the reproductive cycle. The interview should have established reliability and validity with regard to lifetime retrospective information as well as age of onset. 5. The utility of the instrument would profit substantially from incorporating dimensional aspects (Regier 2007; Shear et al. 2007 ). 6. The interview should be available in a computerized format (CAPI and diagnostic analysis) to avoid costly separate data entry and analysis. 7. Pilot data demonstrating the feasibility of incorporating female-specific questions and modules should be available from at least one clinical setting (see Steiner et al. 2008; Rieder et al. 2009 ).
Based on these considerations the group chose the CIDI platform as the most appropriate, promising and comprehensive interview available in meeting these requirements. This decision was further supported by a number of additional advantages, such as (a) the CIDI is modular and flexible allowing easy incorporation of diagnostic and syndromes modules as well as questionnaires, (b) the availability of existing training programs and (c) the relative ease of reliable administration and analysis. We acknowledged though the well known limitations of a non-clinician interview, ie lack of more subtle psychopathological differentiations a clinician might be able to code, clinical features and clinical severity ratings. Based on these considerations, a series of supplementary additions was designed, incorporated into the existing CIDI, and pilot-tested without changing the established skip rules, diagnostic modules, and algorithms of the CIDI .
The content of the CIDI-VENUS (CIDI-V, Martini et al. 2007a, b; Steiner et al. 2007a, b) 1. Section A The rather brief introductory Section (Section A, Demographics) of the CIDI, which originally only included crude biosocial and socio-demographic information, was supplemented by a series of new questions providing a wide range of female-specific general health information, that cuts across all diagnostic categories. This expansion also links initial answers to subsequent questions in the interview. For example, if the stem questions for menopause are denied, respective questions are skipped later on in the interview (and respectively suppressed in the computerized version). This section also includes a standardized assessment of the respondents' menstrual cycle, pregnancy, postpartum period, peri-and postmenopause as well as a detailed obstetric and gynaecologic history. The questions are partly supported by respondent lists and questionnaires as part of the Respondent Booklet Steiner et al. 2007b ).
Iterative Modules to relate symptoms and disorders to
reproductive stages and menopausal transition in diagnostic sections
Based on this background information collected in Section A, the subsequent diagnostic sections are supplemented by an Iterative Module (see Table 2 ) to assess the temporal association of previously reported symptoms and disorders in each respective Section with regard to menstrual cycle, pregnancy, postpartum period, peri-and postmenopause. These additional questions at the end of the diagnostic Section allow the determination of how onset, course and symptom pattern of the respective syndrome is related to women-specific issues. In the mood, anxiety, eating, somatoform and psychotic disorders sections (psychopathological syndromes sections) the instrument asks specifically about the associated symptoms and their impact (e.g., improvement or worsening, increase or decrease of frequency or symptom magnitude) during the different phases of the menstrual cycle and during pregnancy, postpartum, and menopausal transition. For substance use disorders (use of nicotine, alcohol, drugs) and use of medications (substance use sections) the possible teratogenic effects on the offspring were considered in relation to pregnancy and postpartum, assessing whether the respondent stopped, reduced or continued substance use during pregnancy and breastfeeding (see Table 2 ).
The Section for Depressive Disorders allows for differentiation of the subtypes of major depression including specification of severity (e.g. severe episode with psychotic features).
The Section for Specific Phobias was expanded by questions regarding the strong fear (or avoidance) of pregnancy and delivery. Fertile women who prevent a pregnancy despite of the desire to have a child were asked about excessive avoidance strategies (e.g., usage of several contraception methods), whereas for pregnant women, requested anaesthesia or elective caesarean section were considered to be relevant. The Section of Posttraumatic Stress Disorder is extended by a set of questions concerning the occurrence of potentially traumatic events during pregnancy, associated complications during gestation or childbirth, and experience of childbirth (incl. subsequent psychopathological symptoms). For Eating Disorders additional questions concerning weight gain or weight reduction in connection with pregnancy (incl. Hyperemesis Gavidarum), postpartum, and menopause were added (see Table 1 ).
Probe flow chart and time-related questions
The inclusion of women-specific issues also made it necessary to amend some of the CIDI-specific probe questions that are used for specific symptoms and syndromes to exclude substance-related and somatic-related factors Rubio-Stipec et al. 1993) . Here the instrument allows for an additional specification for serious symptoms which are mainly attributed to menstrual cycle, pregnancy, postpartum, or menopause as a specific variant of a 'somatic condition'.
The analysis of a temporal coincidence of psychological symptoms and women-specific issues further required the expansion of the CIDI time-related questions , allowing now for coding the exact time a particular symptom occurred. Steiner et al. 2007b) The supplementary questions and modules also prompted the need for a considerable expansion of the Respondent Booklet and the incorporation of dimensional scales established in previous research. In particular we added:
Modifications of the Respondent Booklet
-The Born-Steiner Irritability Scale (B-SIS), (Born et al. 2008 ) which is a self-rating scale to assess irritability, a prominent symptom in the spectrum of Iterative module: substance use sections Pregnancy Did you (use substance X) when you learned that you were pregnant? Did you completely stop/ reduce (using substance X) when you learned that you were pregnant? Code type and amount per day. Breastfeeding Did you (use substance X) when you were breastfeeding? Did you completely stop/ reduce (using substance X) when you were breastfeeding? Code type and amount per day.
Questions were partly adapted to the content of the respective section (e.g., asking for severity or frequency instead of or additionally to worsening)
female-specific mood disorders (Born and Steiner 2000) . -The Premenstrual Symptoms Screening Tool (PSST), (Steiner et al. 2003b ) which was developed on the basis of DSM-IV research criteria for the Premenstrual Dysphoric Disorder (APA 2000) and reflects these criteria with additional severity ratings. -The Edinburgh Postnatal Depression Scale (EPDS) (Cox et al. 1987 ) as a short, reliable, valid and widely and internationally accepted screening questionnaire to assess depression and anxiety during pregnancy and the postpartum period. -The Greene Climacteric Scale (Greene 1998 ) as a reliable and valid questionnaire, which measures psychological, somatic, and vasomotor menopausal symptoms. -The Perinatal Obsessive-Compulsive Scale (POCS) (Lord et al. 2008) -The Menopause Visual Analogue Scales (M-VAS) ) (see Table 1 ).
Diagnostic analysis and output
Maintaining the integrity of the overall computerized algorithmic platform for the standard sections of the CIDI, we expanded the CIDI output that typically only reveals categorical diagnostic information (for threshold and subthreshold disorders, core syndromes and information about onset, subtype and recency) . The CIDI-Venus standard output (see Fig. 1 ) was supplemented by:
-women-specific information regarding the individual gynaecological history (e.g., menarche, abdominal operations, and hormonal therapy), -adverse pregnancy outcomes (number and dates of abortions, miscarriages, stillbirths, or sudden infant death), -number of children and information concerning birth outcomes (e.g., gestational age, birth weight and length, duration of childbirth), -the PSST and the corresponding decision rules (Steiner et al. 2003b ) as well as scoring of the EPDS, the Greene Climacteric Scale, the M-VAS, and the POCS (Cox et al. 1987; Greene 1998; Lord et al. 2008) The output for each diagnosis shows whether the respondent attributes the beginning or an aggravation of the reported psychopathological syndromes to womenspecific issues (menstrual cycle, pregnancy, postpartum, or menopause). It also provides information about termination or reduction in substance use during pregnancy and while breastfeeding.
Conclusion and outlook
The standardized question format of the CIDI-V provides a systematic and comprehensive approach to current femalespecific core questions in mental disorders and psychopathological research, allowing a reliable examination of a wide range of mental disorders with embedded modular additions of women-specific conditions and factors (menstruation, pregnancy, postpartum, or menopause). The availability of a standardized and comprehensive categorical and dimensional examination of mental disorders and psychopathological syndromes during pregnancy as well as pregnancy and delivery outcomes (e.g., gestational age, mode of delivery) is expected to provide an extensive and solidly coordinated basis for cross-sectional and longitudinal studies in epidemiological and clinical settings. Linked to the already existent family-genetic CIDI version (Lieb et al. 2000 ) the instrument might also enhance the efficiency and the detail of studies dealing with the familial transmission of mental disorders as well as perinatal research in general.
The development of a male-specific CIDI supplement might be a future challenge, aiming a more detailed examination of gender-differences as well as an investigation of conditions that are more common in men (e.g. ADHD, autism spectrum disorders) (van Engeland and Buitelaar 2008; Wittchen and Jacobi 2005) .
The CIDI-V was primarily developed for epidemiological studies to examine women-specific disorders, but it can also be used for clinical practice. Particularities concerning occurrence (prevalence and incidence), maintenance, comorbidity patterns, and temporal relationships with the female reproductive cycle may be explored on this basis more comprehensively. The CIDI-V utility is enhanced by further covering critical issues like the impact of adverse pregnancy outcomes (e.g. stillbirth) and consequences of abdominal operations.
The CIDI-V is available as lifetime and 12-month crosssectional CAPI as well as paper and pencil version in English (Steiner et al. 2007a, b) and German (Martini et al. 2007a, b) . The psychometric exploration of CIDI-V is currently underway; however one would expect that the reliability and validity of diagnostic sections and embedded instruments will not differ significantly from those in previous studies, given that only some of the context variables are different.
